07:00 , Aug 10, 2015 |  BC Week In Review  |  Company News

Amoun, Valeant Pharmaceuticals deal

Valeant will acquire Amoun for $800 million. Amoun markets antihypertensives, broad-spectrum antibiotics and antidiarrheals. Valeant plans to use the acquisition to expand into the Middle East and North African markets. Valeant said Amoun expects to...